Imkeldi 80 mg/mL oral solution Images

Generic Name: imatinib

This medication has been identified as Imkeldi 80 mg/mL oral solution. It is supplied by Shorla Oncology Inc.

Imkeldi is used in the treatment of Chronic Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Dermatofibrosarcoma Protuberans; Chronic Eosinophilic Leukemia; Gastrointestinal Stromal Tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imkeldi 80 mg/mL oral solution is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Imkeldi

Generic Name

imatinib

Strength

80 mg/mL oral solution

Availability

Prescription only

Drug Class

BCR-ABL tyrosine kinase inhibitors

Pregnancy Category

D - Positive evidence of risk

CSA Schedule

Not a controlled drug

Labeler / Supplier

Shorla Oncology Inc.

National Drug Code (NDC)

81927-0201

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer